SeaStar Medical Holding Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ICUCW | CDNA | MMSI | OBIO | REVB | CTSO | |
|---|---|---|---|---|---|---|
| Market cap | — | 3.31B | 5.33B | 327.57M | 1.93M | 12.95M |
| P/E (TTM) | — | 30.8 | 36.7 | — | 0.1 | — |
| Forward P/E | — | 49.6 | 19.3 | -3.6 | -0.2 | — |
| Price/book | 0.0 | 7.7 | 3.2 | 17.0 | 0.2 | -17.2 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | — | +320.50% | +7.20% | +39.74% | −90.38% | −75.82% |
| Today | 0.00% | −4.01% | −0.41% | −5.05% | −35.80% | +34.31% |
The closest companies by business. Prices may be delayed up to 15 min.
Latest news
All ICUCW news ›SeaStar Medical Chief Medical Officer Kevin Chung, MD, Named 2026 Recipient of the Combat Nephrology Award
Award recognizes Dr. Chung’s extraordinary career as an internationally known expert in burn critical care, combat casualty care, acute organ failure, and extracorporeal organ support Keynote presentation and award ceremony to occur at…
SeaStar Medical Receives FDA Breakthrough Device Designation for SCD Therapy in Adult Sepsis and Septic Conditions
The FDA granted SeaStar Medical Breakthrough Device Designation for its SCD therapy to treat hyperinflammation in sepsis patients. The SCD therapy has received seven Breakthrough Device Designations across various medical conditions,…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
manilatimes.net2
-
quiverquant.com1
-
stocktitan.net1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.